Sacituzumab Govitecan Toxicity Outcomes In Arab Patients with Metastatic Breast Cancer

被引：0
|
作者：
Altarturi, Maymouna
Suleman, Kausar
AlSayed, Adhar
Al-Shamsi, Humaid
Alawadhi, Aydah
Basuliamn, Bassam
Alaklabi, Sabah
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-12-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-12-10
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Sacituzumab Govitecan in Metastatic Breast Cancer
    Ganguly, Shuvadeep
    Gogia, Ajay
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
  • [2] Sacituzumab-govitecan in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01)
  • [3] Sacituzumab Govitecan in Metastatic Breast Cancer REPLY
    Bardia, Aditya
    Hurvitz, Sara A.
    Rugo, Hope S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
  • [4] Sacituzumab govitecan in breast cancer
    Wang, Xiaojun
    Chen, Jiongjie
    Xiao, Hua
    Shi, Yang
    TRANSLATIONAL BREAST CANCER RESEARCH, 2021, 2
  • [5] Sacituzumab Govitecan for treating Patients with metastatic triple-negative Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (12) : 1271 - 1271
  • [6] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Hurvitz, S. A.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Oliveira, M.
    Brufsky, A.
    Sardesai, S. D.
    Kalinsky, K.
    Zelnak, A. B.
    Weaver, R.
    Traina, T.
    Dalenc, F.
    Aftimos, P.
    Lynce, F.
    Diab, S.
    Cortes, J.
    O'Shaughnessy, J.
    Dieras, V
    Ferrario, C.
    Schmid, P.
    Carey, L. A.
    Gianni, L.
    Piccart, M. J.
    Loibl, S.
    Goldenberg, D. M.
    Hong, Q.
    Olivo, M. S.
    Itri, L. M.
    Rugo, H. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1529 - 1541
  • [7] Real-world outcomes of sacituzumab govitecan in breast cancer
    Singh, Vaishnavi
    Dhaibar, Hemangini
    Peddi, Prakash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
    Ergun, Yakup
    LANCET, 2024, 404 (10450): : 337 - 338
  • [9] Sacituzumab govitecan versus chemotherapy for metastatic breast cancer: A meta-analysis on safety outcomes
    Rizzo, A.
    Rinaldi, L.
    Massafra, R.
    Cusmai, A.
    Guven, D. C.
    La Forgia, D.
    Latorre, A.
    Giotta, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S356 - S356
  • [10] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer
    Sg, Nithin
    Gogia, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08)
12345